SCHEMBL572273

SCHEMBL572273

COc1ccc([C@]2(O)Cc3ccc(O)cc3OC2=O)c(O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.41
TYR P14679 1/20 0.39
MIF P14174 1/20 0.39
KIT P10721 1/20 0.39
ALDH1A1 P00352 3/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 1/20 0.38
RECQL P46063 1/20 0.38
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
MAOB P27338 1/20 0.37
KDM4E B2RXH2 2/20 0.36
PTPN1 P18031 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KLK7 P49862 1/20 0.36
PTGS2 P35354 1/20 0.36
CES2 O00748 1/20 0.36
ALOX5 P09917 1/20 0.36
MGAM O43451 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17963718 1.00 NR1H4 (0.41) NR1H4TYRMIFKITALDH1A1
SCHEMBL17867147 0.76 ALDH1A1 (0.37) TYRMIFALDH1A1KMT2ARECQL
SCHEMBL501806 0.76 ALDH1A1 (0.41) NR1H4TYRALDH1A1KMT2AMEN1
(3R)-4'-Methoxy-2',3',7-Trihydroxyisoflavanone SCHEMBL17963716 0.75 PTPN1 (0.61) NR1H4TYRKITALDH1A1KMT2A
(3R)-4'-Methoxy-2',3',7-Trihydroxyisoflavanone SCHEMBL30217561 0.75 PTPN1 (0.61) NR1H4TYRKITALDH1A1KMT2A
(3R)-4'-Methoxy-2',3',7-Trihydroxyisoflavanone SCHEMBL572272 0.75 PTPN1 (0.61) NR1H4TYRKITALDH1A1KMT2A
SCHEMBL28470256 0.74 NR1H4 (0.39) NR1H4TYRALDH1A1KMT2AMEN1
SCHEMBL8869451 0.71 DRD2 (0.44) NR1H4TYRMIFKITALDH1A1
SCHEMBL26779088 0.67 KIT (0.53) TYRMIFKITALDH1A1KMT2A
SCHEMBL28316491 0.67 PTPN1 (0.48) NR1H4TYRKITALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2014-08-21 US disclosed
US-8748177-B2 Compositions for proliferation of cells and related methods THE HOSPITAL FOR SICK CHILDREN (CA) 2014-06-10 US disclosed
EP-2598150-A2 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS The Hospital For Sick Children (CA) 2013-06-05 EP disclosed
WO-2012018643-A2 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2012-02-09 WO disclosed
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2011-12-08 US disclosed
WO-2010039679-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2010-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 NR1H4 1800/4885TYR 141/4885MIF 3258/4885
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 NR1H4 1800/4885TYR 141/4885MIF 3258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.